4clj
From Proteopedia
(Difference between revisions)
m (Protected "4clj" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4clj is ON HOLD | + | The entry 4clj is ON HOLD until Paper Publication |
Authors: McTigue, M., Deng, Y., Liu, W., Brooun, A., Stewart, A. | Authors: McTigue, M., Deng, Y., Liu, W., Brooun, A., Stewart, A. | ||
Description: Structure of L1196M Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922 ((10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile). | Description: Structure of L1196M Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922 ((10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile). | ||
Revision as of 08:11, 2 April 2014
Unreleased structure
The entry 4clj is ON HOLD until Paper Publication
Authors: McTigue, M., Deng, Y., Liu, W., Brooun, A., Stewart, A.
Description: Structure of L1196M Mutant Human Anaplastic Lymphoma Kinase in Complex with PF-06463922 ((10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile).
